The use of a microsomal in vitro assay to study phase I biotransformation of chlorobornanes (toxaphene (R)) in marine mammals and birds - Possible consequences of biotransformation for bioaccumulation and genotoxicity

Citation
Jp. Boon et al., The use of a microsomal in vitro assay to study phase I biotransformation of chlorobornanes (toxaphene (R)) in marine mammals and birds - Possible consequences of biotransformation for bioaccumulation and genotoxicity, COMP BIOC C, 121(1-3), 1998, pp. 385-403
Citations number
31
Categorie Soggetti
Pharmacology & Toxicology
Journal title
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY
ISSN journal
13678280 → ACNP
Volume
121
Issue
1-3
Year of publication
1998
Pages
385 - 403
Database
ISI
SICI code
1367-8280(199811)121:1-3<385:TUOAMI>2.0.ZU;2-8
Abstract
The factors determining the bioaccumulation of lipophilic compounds in wild life are often poorly understood, partly because it is difficult to do in v ivo experiments with animals such as marine mammals and birds. To evaluate the role of phase I biotransformation in the bioaccumulation process of chl orobornanes (toxaphene(R)), this was studied in in vitro assays with hepati c microsomes of animals that could be sampled shortly after death. The capa city of microsomes to metabolise a technical toxaphene mixture decreased in the order Phoca vitulina (harbour seal) much greater than lagenorhynchus a lbirostris (whitebeaked dolphin) congruent to Diomedea immutabilis (Laysan albatross) > Physeter macrocephalus (:sperm whale). Harbour seal microsomes metabolised the chlorobornane (CHB) congeners CHB-32 and CHB-62; whitebeak ed dolphin and Laysan albatross microsomes only metabolised CHB-32. Metabol ism of CHB-26 and CHB-50 was never observed. The negative chemical ionisati on (NCI -) mass spectra of some of the hydroxylated metabolites were obtain ed. The number of peaks in the toxaphene residues of wildlife extracts decr eased in the order of increasing in-vitro biotransformation capacity. Thus, the results of the in vitro assays and residue analysis were in accordance , although assays with microsomes of more individuals of the same species a re required for a more general conclusion at the species level. Finally, th e effect of in vitro biotransformation was evaluated in terms of the genoto xic potential using the Mutatox(R) assay. Only technical toxaphene and CHB- 32 were genotoxic in the direct assay, whereas the addition of rat S9 fract ion or microsomes of harbour seal and albatross decreased the genotoxic res ponse. Thus, organisms with a low ability to metabolise chlorobornanes, suc h as whales, may be most affected by the carcinogenic properties of toxaphe ne. A hypothetical reaction which fits the experimental results is discusse d. Based on these results it is concluded that in vitro assays with microso mes of wildlife animals which died a natural cause can act as a valuable to ol to assess the occurrence and effects of phase I metabolism. Some precaut ions are discussed, that should be taken to reduce the chance of false nega tive results. (C) 1998 Published by Elsevier Science Inc. All rights reserv ed.